Acceptable incremental cost effectiveness ratio for use of new drugs, cases in statin therapies.
Nakao
Susumu
S
Social and Administrative Pharmacy Science Unit, School of Pharmacy, Nihon University, Funabashi, Chiba, Japan.
Kawabe
Hiroyuki
H
Takuma
Hiroki
H
Shiragami
Makoto
M